As Johnson spoke on the library steps, protesters at the encampment nearby appeared to pay little attention
J&J's experimental dengue pill prevents infection in mice, monkeys
The company said in a statement it has already completed an early-stage trial of the experimental treatment, known as JNJ-1802
Published : 15 March 2023, 08:50 PM
Updated : 15 March 2023, 08:50 PM
An experimental pill for dengue developed by Johnson & Johnson proved effective against all four types of the virus in mice and prevented infection from two types in monkeys, according to data published on Wednesday.
The promising early animal results appearing in the journal Nature add hope for what could become the first antiviral treatment for a mosquito-borne disease that causes 96 million symptomatic infections and 10,000 deaths each year.
The company said in a statement it has already completed an early-stage trial of the experimental treatment, known as JNJ-1802, in healthy human volunteers, which showed it to be safe and well tolerated. J&J is now testing the drug in a randomized Phase II clinical trial.
Studies in lab animals confirmed prior work showing the drug blocks the action of two viral proteins, preventing the virus from making copies of itself.
The company said in a statement it aims to develop the drug as both a treatment for dengue and to prevent infections.
RELATED STORIES
Ukrainian President Volodymyr Zelensky expressed his thanks, saying US lawmakers moved to keep "history on the right track"
The Senate is expected to pass the measure next week, sending it to Biden to sign into law
The measure aims to provide security assistance to Ukraine, Israel and Taiwan over bitter objections from party hardliners
